BANK OF AMERICA CORP /DE/ - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,626
-44.6%
8,782
-33.7%
0.00%
Q2 2023$19,193
-28.1%
13,237
-28.1%
0.00%
Q1 2023$26,705
+94.5%
18,417
+132.0%
0.00%
Q4 2022$13,733
-27.7%
7,938
-18.8%
0.00%
Q3 2022$19,000
+35.7%
9,781
-47.3%
0.00%
Q2 2022$14,000
-83.5%
18,575
+89.3%
0.00%
Q1 2022$85,000
-87.3%
9,810
-76.4%
0.00%
Q4 2021$667,000
+165.7%
41,653
+204.7%
0.00%
Q3 2021$251,000
+134.6%
13,668
+77.5%
0.00%
Q2 2021$107,000
-61.4%
7,701
-59.1%
0.00%
Q1 2021$277,000
+59.2%
18,819
+109.8%
0.00%
Q4 2020$174,000
+4.2%
8,969
-40.3%
0.00%
Q3 2020$167,000
-26.1%
15,012
-10.4%
0.00%
Q2 2020$226,000
+182.5%
16,748
+68.8%
0.00%
Q1 2020$80,000
-54.3%
9,919
-45.6%
0.00%
Q4 2019$175,000
+10.1%
18,226
+21.7%
0.00%
Q3 2019$159,000
+21.4%
14,973
+31.7%
0.00%
Q2 2019$131,000
-87.6%
11,370
-86.2%
0.00%
Q1 2019$1,055,000
+106.9%
82,439
-0.7%
0.00%
Q4 2018$510,000
+1143.9%
83,009
+2036.1%
0.00%
Q3 2018$41,000
+46.4%
3,886
+106.6%
0.00%
Q2 2018$28,000
+366.7%
1,881
+309.8%
0.00%
Q1 2018$6,000
-50.0%
459
-52.6%
0.00%
Q4 2017$12,0009690.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders